These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15841304)

  • 1. Amalfi to Washington D. C.--twenty years of plasminogen activator research.
    Antalis TM; Bugge TH; Lawrence DA; Netzel-Arnett S; Schwartz BS; Strickland DK
    Thromb Haemost; 2005 Apr; 93(4):625-6. PubMed ID: 15841304
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action.
    Gurewich V
    Semin Thromb Hemost; 1988 Jan; 14(1):110-5. PubMed ID: 3127884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasminogen activators in tumor tissue].
    Tomasiuk R; Mirowski M; Wierzbicki R
    Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455
    [No Abstract]   [Full Text] [Related]  

  • 4. Human plasminogen activators. Genes and proteins structure.
    Blasi F; Riccio A; Sebastio G
    Horiz Biochem Biophys; 1986; 8():377-414. PubMed ID: 3093360
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasminogen activator-dependent pericellular proteolysis.
    Scully MF
    Br J Haematol; 1991 Dec; 79(4):537-43. PubMed ID: 1663384
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular mechanisms in the hormonal regulation of plasminogen activator activity in ovarian granulosa cells and cumulus-oocyte complexes.
    Hsueh AJ; Liu YX; Cajander SB; Ny T
    Prog Clin Biol Res; 1988; 267():227-57. PubMed ID: 3148935
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of plasminogen activators.
    Robbins KC; Barlow GH; Nguyen G; Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):131-8. PubMed ID: 3114881
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. 1991.
    Grompe M
    J Hepatol; 2002 Oct; 37(4):422-4. PubMed ID: 12217593
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuronal cell death and tPA.
    Tsirka SE; Rogove AD; Strickland S
    Nature; 1996 Nov; 384(6605):123-4. PubMed ID: 8906786
    [No Abstract]   [Full Text] [Related]  

  • 11. DDAVP and factor VIII: a tale from Edinburgh.
    Cash JD
    J Thromb Haemost; 2003 Apr; 1(4):619-21. PubMed ID: 12871388
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen activators and cancer.
    Duffy MJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):681-7. PubMed ID: 2133247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in fibrinolysis mediated by vascular endothelial cells].
    Zhou QS
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):318-22. PubMed ID: 2129251
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery of thrombin activatable fibrinolysis inhibitor (TAFI).
    Bertina RM; van Tilburg NH; Haverkate F; Bouma BN; von dem Borne PA; Meijers JC; Campbell W; Eaton D; Hendriks DF; Willemse JL
    J Thromb Haemost; 2006 Jan; 4(1):256-7. PubMed ID: 16409476
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone regulation of tissue-type plasminogen activator gene expression and plasminogen activator-mediated proteolysis.
    Ohlsson M; Peng XR; Liu YX; Jia XC; Hsueh AJ; Ny T
    Semin Thromb Hemost; 1991 Jul; 17(3):286-90. PubMed ID: 1796299
    [No Abstract]   [Full Text] [Related]  

  • 17. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
    Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrinsic plasminogen activator response to exercise after a single dose of propranolol.
    el-Sayed MS
    Med Sci Sports Exerc; 1992 Mar; 24(3):327-32. PubMed ID: 1549027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.